MONTANA PUBLIC HEALTH INSTITUTE
Bozeman, MT, US
•
501(c)3
•
EIN
85-1137954
•
•
Research Institutes & Public Policy Analysis
Regional Funder
Bozeman, MT, US
•
501(c)3
•
EIN
85-1137954
•
•
Research Institutes & Public Policy Analysis
Regional Funder
Programs
Montana Public Health Initiative
MONTANA PUBLIC HEALTH INSTITUTE DEVELOPED TOOLKITS FOR STATE AND TRIBAL HEALTH DEPARTMENTS TO REVIEW CURRENT COVID-19 VACCINE DISTRIBUTION METHODS, ALLOWING THESE DEPARTMENTS TO IDENTIFY AND ADDRESS ANY EXISTING GAPS IN THESE DEPARTMENT'S VACCINE METHODOLOGY. THE INSTITUTE ALSO DEVELOPED MARKETING MATERIALS TO PROMOTE THE DIFFERENT COUNSELING SERVICES AVAILABLE TO THOSE IMPACTED BY COVID-19. FINALLY, THE MONTANA PUBLIC HEALTH INSTITUTE LED THE DEVELOPMENT OF A CRISIS COORDINATOR NETWORK, ALLOWING MULTIPLE AGENCIES IN THE STATE OF MONTANA TO LINK THEIR WORK WITH EACHOTHER.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$430.9KLocal Health Department Support
THE MONTANA PUBLIC HEALTH INSTITUTE WORKED TO SUPPORT LOCAL HEALTH DEPARTMENTS ACROSS MONTANA TO INCREASE THE ABILITY OF THESE DEPARTMENTS TO RESPOND TO PUBLIC HEALTH NEEDS. THIS WAS ACCOMPLISHED BY ASSISTING WITH THE DEVELOPMENT AND IMPLEMENTATION OF PLANS AND POLICIES DIRECTED AT HEALTH IMPROVEMENT. ADDITIONALLY, MONTANA PUBLIC HEALTH INSTITUTE ASSISTED WITH THE REGULAR HEALTH DEPARTMENT MANAGEMENT, ASSISTING WITH COMMUNITY HEALTH PLANNING ACTIVIES, AND INCREASING THE CAPAPCITY OF LOCAL AND TRIBAL HEALTH DEPARTMENTS TO ADDRESS PERSONEL SHORTFALLS.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$336.2KAccess to Treatment for Opioid Disorders
THE MONTANA PUBLIC HEALTH INSTITUTE HELPED INCREASE ACCESS TO TREATMENT FOR UNDERSERVED POPULATIONS SUFFERING FROM OPIOID USE DISORDER AND STIMULANT USE DISORDER. IN ADDITION TO EVALUATING OUTCOMES AND PROVIDING PROGRAM SUPPORT, THE MONTANA PUBLIC HEALTH INSTITUTE ASSISTED WITH THE COMPLETION OF AGREEMENTS WITH MULTIPLE STATE, LOCAL, AND TRIBAL ORGANIZATIONS ALLOWING FOR THESE AGENCIES TO DISTRIBUTE NALOXONE, AN EVIDENCE-BASED TREATMENT FOR THESE DISORDERS.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$429.5K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)